Origin Merchant Securities Inc. is pleased to announce that Pivot Pharmaceuticals Inc. has successfully completed a $5 million private placement of convertible debentures.
Origin Merchant Securities Inc. acted as exclusive financial advisor to Pivot with respect to this transaction.
Pivot Pharmaceuticals Inc. (“Pivot”) is a vertically-integrated cannabis company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s proprietary topical and oral drug delivery technologies improve the bioavailability of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC)-based products. Pivot’s initial product development candidates will include topical treatments for women’s sexual dysfunction, as well as psoriasis, and an oral product for cancer supportive care.
Origin Senior Lead: Cathy Steiner
